Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 12

2.

3-Nitropropionic acid animal model and Huntington's disease.

Borlongan CV, Koutouzis TK, Sanberg PR.

Neurosci Biobehav Rev. 1997 May;21(3):289-93. Review.

PMID:
9168265
3.

3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease.

Brouillet E, Jacquard C, Bizat N, Blum D.

J Neurochem. 2005 Dec;95(6):1521-40. Epub 2005 Nov 21. Review.

5.

Replicating Huntington's disease phenotype in experimental animals.

Brouillet E, Condé F, Beal MF, Hantraye P.

Prog Neurobiol. 1999 Dec;59(5):427-68. Review.

PMID:
10515664
6.
7.

Animal models of Huntington's disease.

Ramaswamy S, McBride JL, Kordower JH.

ILAR J. 2007;48(4):356-73. Review.

8.

[Model of Huntington's disease induced with 3-nitropropionic acid].

Túnez I, Santamaría A.

Rev Neurol. 2009 Apr 16-30;48(8):430-4. Review. Spanish.

9.

3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin.

Ludolph AC, He F, Spencer PS, Hammerstad J, Sabri M.

Can J Neurol Sci. 1991 Nov;18(4):492-8. Review.

PMID:
1782616
10.

Neurochemistry and toxin models in Huntington's disease.

Beal MF.

Curr Opin Neurol. 1994 Dec;7(6):542-7. Review.

PMID:
7866587
11.

3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington's disease: past, present and future.

Túnez I, Tasset I, Pérez-De La Cruz V, Santamaría A.

Molecules. 2010 Feb 10;15(2):878-916. doi: 10.3390/molecules15020878. Review.

12.

Effects of chronic MPTP and 3-nitropropionic acid in nonhuman primates.

Brouillet E, Hantraye P.

Curr Opin Neurol. 1995 Dec;8(6):469-73. Review.

PMID:
8845934
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk